Remove Bioavailability Remove Genotoxicity Remove In-Vivo Remove Scientist
article thumbnail

The Composition and Value of a Portfolio Analysis

Camargo

Clinical pharmacology may also involve comparative bioavailability analyses, which are generally required for drug formulation bridging studies, to demonstrate bioequivalence. Gaining a thorough understanding of these factors can significantly impact development strategy and increase the likelihood of marketplace success.